← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.4M of Moderna, Inc.

Sold$1,372,500
$137.25Price
10,000Shares

What MRNA did after the filing

Filed Oct 28Copier in Oct 31
The stock from Mon, Oct 31 open, $149.43
+32.2%
S&P 500, same days
+4.0%

Measured over 30 trading days, to the Dec 13 close.

Traded Wed, Oct 26. Filed Fri, Oct 28, 7:30 PM ET, after the close. Returns use the Oct 31 open and the Dec 13 close. Not investment advice.